An Open-label, Prospective, Randomized, Multi-center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients.
This study has been completed.
Information provided by:
First received: October 6, 2005
Last updated: July 31, 2009
Last verified: October 2006
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||June 2005|
|Primary Completion Date:||April 2003 (Final data collection date for primary outcome measure)|